期刊簡介 | |||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
期刊名稱 | Bioengineering & Translational Medicine LetPub Score 7.2
50 ratings
Rate
Reputation 8.6 Influence 6.0 Speed 7.0 | ||||||||||||||||||||||||
期刊簡稱 | BIOENG TRANSL MED | ||||||||||||||||||||||||
ISSN | 2380-6761 | ||||||||||||||||||||||||
h-index | N.A. | ||||||||||||||||||||||||
CiteScore |
| ||||||||||||||||||||||||
自引率 (2023-2024) | 3.30%自引率趨勢 | ||||||||||||||||||||||||
掲載範囲 |
| ||||||||||||||||||||||||
官方網站 | http://onlinelibrary.wiley.com/journal/10.1002/(ISSN)2380-6761 | ||||||||||||||||||||||||
在線稿件提交 | |||||||||||||||||||||||||
開放訪問 | Yes | ||||||||||||||||||||||||
出版商 | Wiley-Blackwell | ||||||||||||||||||||||||
主題領域 | Pharmacology, Toxicology and Pharmaceutics | ||||||||||||||||||||||||
出版國/地區 | UNITED STATES | ||||||||||||||||||||||||
發行頻率 | |||||||||||||||||||||||||
創刊年 | 0 | ||||||||||||||||||||||||
每年文章數 | 152每年文章數趨勢 | ||||||||||||||||||||||||
黃金OA百分比 | 77.89% | ||||||||||||||||||||||||
OA Related Info | APC: Yes( USD2750; GBP1710; EUR2150; ) APC waiver:Check Notes Other charges: No Keywords: drug delivery、tissue engineering、synthetic biology、biosensors、biomolecular engineering、immunotherapy Useful LinksAims & ScopeAuthor InstructionsEditorial BoardPeer review、Anonymous peer review | ||||||||||||||||||||||||
Web of Science 四分位 ( 2023-2024) | WOS Quartile: Q1
| ||||||||||||||||||||||||
索引 (SCI or SCIE) | Science Citation Index Expanded | ||||||||||||||||||||||||
鏈接到PubMed Central (PMC) | https://www.ncbi.nlm.nih.gov/nlmcatalog?term=2380-6761%5BISSN%5D | ||||||||||||||||||||||||
平均審稿時間 * | 來自出版商的數據: 來自作者的數據: 12 Weeks | ||||||||||||||||||||||||
競爭力 * | 來自作者的數據: | ||||||||||||||||||||||||
參考鏈接 |
| ||||||||||||||||||||||||
*所有的審稿過程指標,如接受率和審稿速度,僅限於用戶提交的稿件。因此,這些指標可能無法準確反映期刊的競爭力或速度。 |
|
首頁 上一頁 1 下一頁 末頁 (頁 | |
[Bioengineering & Translational Medicine] 的評論 | 撰寫評論 |
作者: yangyangyang9999 領域: 医学 審稿時間: 6.0 month(s) 結果: 直接被接受 撰寫評論 |
2023-06-29 08:25:58 評論於 Overall, I did a good job, and the speed was fast. However, it is important to note that submitting for review does not guarantee an opportunity. Feedback is crucial when coming back.(0) 讚! | yangyangyang9999 |
作者: 临窗观景1 領域: 医学 審稿時間: 2.0 month(s) 結果: 修改後接受 撰寫評論 |
2023-05-27 15:11:32 評論於 The editors and reviewers are very professional, and the questions they raised are very valuable. I hope it will continue to improve.(1) 讚! | 临窗观景1 |
作者: 花间笑 領域: 生物学 審稿時間: 3.0 month(s) 結果: 修改後接受 撰寫評論 |
2022-12-08 20:34:56 評論於 Posted on July 19, 2022, major revisions on September 2, 2022, due to the slow progress in conducting experiments caused by the pandemic. Revised again on November 1, 2022, and accepted on December 1, 2022. Perhaps because the topic of the research is relatively niche, there were only two reviewers, but their comments were very fair and practical. I hope the journal continues to thrive!(1) 讚! | 花间笑 |
作者: Ge Wang 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2022-09-13 20:47:50 評論於 Is it normal for 5 months to be under review?(0) 讚! | Ge Wang |
作者: 神学尽头的科学 領域: 生物学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2022-04-13 07:29:51 評論於 Are you still there?(0) 讚! | 神学尽头的科学 |
作者: 神学尽头的科学 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2022-04-05 18:47:01 評論於 May I ask, it has been almost two weeks since I submitted to this journal, but it has been under review from the beginning and is still with the editor. Could you please tell me what changes in status occur during the submission process? How can I confirm if it has been sent for external review? Thank you so much.(0) 讚! | 神学尽头的科学 |
作者: 吃树好吃 領域: 医学 審稿時間: 12.0 month(s) 結果: 待定&不明 撰寫評論 |
2022-01-06 09:45:05 評論於 Hello, I submitted my manuscript on October 31st. On January 2nd, the status changed from "under review" to "pending recommendation," and it has remained the same since then. How long does "pending recommendation" usually last? I have previously sent a reminder letter, but the editor has not replied...(0) 讚! | 吃树好吃 |
作者: 邓昌平 領域: 生物学 審稿時間: 3.0 month(s) 結果: 修改後接受 撰寫評論 |
2021-12-28 16:15:20 評論於 10-Oct-2021投;30-Oct-2021大修;20-Nov-2021修回;19-Dec-2021小修;20-Dec-2021修回;25-Dec-2021接收;整体投稿还算顺利,审稿人问题很有水平,很中肯,直击要害。 Translation: 10-Oct-2021 Submission; 30-Oct-2021 Major revisions; 20-Nov-2021 Revisions submitted; 19-Dec-2021 Minor revisions; 20-Dec-2021 Revisions submitted; 25-Dec-2021 Accepted; The overall submission process went smoothly, the reviewers' questions were insightful and fair, hitting the key points.(0) 讚! | 邓昌平 |
首頁 上一頁 1 下一頁 末頁 (頁 |
Contact us